PT Medela Potentia Tbk
PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories; and engages in the wholesale trade of laboratory equipment, pharmaceutical tools, and medical instruments for human use, as well as pharmaceutical prod… Read more
Market Cap & Net Worth: PT Medela Potentia Tbk (MDLA)
PT Medela Potentia Tbk (JK:MDLA) has a market capitalization of $129.87 (Rp2.11 Million) as of March 19, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #49953 globally and #908 in its home market, demonstrating a -3.57% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PT Medela Potentia Tbk's stock price Rp216.00 by its total outstanding shares 9782 (9.78K).
PT Medela Potentia Tbk Market Cap History: 2025 to 2026
PT Medela Potentia Tbk's market capitalization history from 2025 to 2026. Data shows growth from $158.73 to $129.87 (0.00% CAGR).
PT Medela Potentia Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PT Medela Potentia Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MDLA by Market Capitalization
Companies near PT Medela Potentia Tbk in the global market cap rankings as of March 19, 2026.
Key companies related to PT Medela Potentia Tbk by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
PT Medela Potentia Tbk Historical Marketcap From 2025 to 2026
Between 2025 and today, PT Medela Potentia Tbk's market cap moved from $158.73 to $ 129.87, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp129.87 | -18.18% |
| 2025 | Rp158.73 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PT Medela Potentia Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $129.87 USD |
| MoneyControl | $129.87 USD |
| MarketWatch | $129.87 USD |
| marketcap.company | $129.87 USD |
| Reuters | $129.87 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.